This is certainly a problem, but there just isn't much that many can do about the laws as they are written (and the whole incentives of the pharmaceutical industry as we know it).

That said, there is some hope on the horizon, some patent expirations have already happened (i.e. liraglutide which is less effective) and some are coming:

https://glp1.guide/content/patent-expirations-for-glp1-recep...